Oncimmune

Oncimmune

Operates as a cancer detection company. The Company focuses on the development of autoantibody assay technologies that allow cancer detection earlier than other methods. Learn more

Launch date
Employees
Market cap
AUD31.9m
Enterprise valuation
AUD41m (Public information from Sep 2024)
Company register number 04606727
Leeds England (HQ)
Authorizing premium user...